These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16463554)

  • 21. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with resistance to dementia despite high Alzheimer disease pathology.
    Fotuhi M; Hachinski V; Kivipelto M; Whitehouse P
    Neurology; 2009 Nov; 73(19):1607; author reply 1607-8. PubMed ID: 19901259
    [No Abstract]   [Full Text] [Related]  

  • 23. Can treatment with nonsteroidal anti-inflammatory drugs protect from dementia?
    Bregman N; Karni A; Korczyn AD
    Arch Neurol; 2009 Apr; 66(4):539-40; author reply 540. PubMed ID: 19364945
    [No Abstract]   [Full Text] [Related]  

  • 24. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease--but how and why?
    Das UN
    Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):11-9. PubMed ID: 18054217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dementia diseases--a systematic review. SBU's summary and conclusions].
    Edhag O; Norlund A
    Lakartidningen; 2006 Jul 12-25; 103(28-29):2135-9. PubMed ID: 16895096
    [No Abstract]   [Full Text] [Related]  

  • 26. Do caregivers' experiences correspond with the concerns raised in the literature? Ethical issues relating to anti-dementia drugs.
    Huizing AR; Berghmans RL; Widdershoven GA; Verhey FR
    Int J Geriatr Psychiatry; 2006 Sep; 21(9):869-75. PubMed ID: 16955453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dementia].
    Sjöbeck M; Nilsson C
    Lakartidningen; 2009 May 13-19; 106(20):1369-73. PubMed ID: 19585832
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cholinesterase inhibitors in dementia: the precarious balance between efficacy and safety].
    Richard E; van Gool WA
    Ned Tijdschr Geneeskd; 2006 Mar; 150(10):530-2. PubMed ID: 16566413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.
    Liepelt I; Maetzler W; Blaicher HP; Gasser T; Berg D
    Dement Geriatr Cogn Disord; 2007; 23(6):351-67. PubMed ID: 17389795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New therapeutic options in Alzheimer's disease].
    García-Ruiz Espiga PJ; Echeverría A; García-Torres A; Contreras A
    Rev Neurol; 2006 Apr 16-30; 42(8):478-81. PubMed ID: 16625510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rate of progression differs in frontotemporal dementia and Alzheimer disease.
    Kertesz A
    Neurology; 2006 May; 66(10):1607; author reply 1607. PubMed ID: 16717240
    [No Abstract]   [Full Text] [Related]  

  • 32. The case for alcohol in the primary prevention of dementia: abstinence may be bad for your health!
    Sherman FT
    Geriatrics; 2006 Aug; 61(8):10-2. PubMed ID: 16901191
    [No Abstract]   [Full Text] [Related]  

  • 33. Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing!
    Tabet N
    Age Ageing; 2006 Jul; 35(4):336-8. PubMed ID: 16788077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychiatric outcome for clinical trials.
    Robert P; Verhey FR; Aalten P; Cortes F; Byrne EJ
    J Nutr Health Aging; 2007; 11(4):345-7. PubMed ID: 17653496
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased frontal phase-locking of event-related theta oscillations in Alzheimer patients treated with cholinesterase inhibitors.
    Yener GG; Güntekin B; Oniz A; Başar E
    Int J Psychophysiol; 2007 Apr; 64(1):46-52. PubMed ID: 17011650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer disease and its management: a review.
    Samanta MK; Wilson B; Santhi K; Kumar KP; Suresh B
    Am J Ther; 2006; 13(6):516-26. PubMed ID: 17122533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of dementia: anything new?
    Machado JC; Caramelli P
    Curr Opin Psychiatry; 2006 Nov; 19(6):575-80. PubMed ID: 17012934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing CSF phospho-tau levels during cognitive decline and progression to dementia.
    Andersson C; Blennow K; Almkvist O; Andreasen N; Engfeldt P; Johansson SE; Lindau M; Eriksdotter-Jönhagen M
    Neurobiol Aging; 2008 Oct; 29(10):1466-73. PubMed ID: 17512092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias.
    Di Lazzaro V; Pilato F; Dileone M; Saturno E; Oliviero A; Marra C; Daniele A; Ranieri F; Gainotti G; Tonali PA
    Neurology; 2006 Apr; 66(7):1111-3. PubMed ID: 16606932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early diagnosis of dementia in primary care.
    Stoppe G; Maeck L
    Int J Geriatr Psychiatry; 2007 May; 22(5):498. PubMed ID: 17471594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.